Cargando…
Identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patients
Autores principales: | Tan, Zheng, D’Costa, Ninadh M., Raven, Peter A., Chavez-Munoz, Claudia, So, Alan I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881214/ https://www.ncbi.nlm.nih.gov/pubmed/29644173 http://dx.doi.org/10.21037/tau.2017.12.17 |
Ejemplares similares
-
Identification of gene signature for treatment response to guide precision oncology in clear-cell renal cell carcinoma
por: D’Costa, Ninadh M., et al.
Publicado: (2020) -
The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinib
por: Frees, Sebastian, et al.
Publicado: (2018) -
Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma
por: D’Costa, Ninadh M., et al.
Publicado: (2020) -
The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Monjaras-Avila, Cesar U., et al.
Publicado: (2023) -
A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder Cancer
por: D’Costa, Jamie J., et al.
Publicado: (2016)